Page last updated: 2024-10-22

amlodipine and Sclerosis, Systemic

amlodipine has been researched along with Sclerosis, Systemic in 3 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gholam, P1
Sehr, T1
Enk, A1
Hartmann, M1
Schorn, R1
Gaspert, A1
Cohen, CD1
Szabolcsi, O1
Nagy-Toldi, A1
Zeher, M1
VĂ©gh, J1

Other Studies

3 other studies available for amlodipine and Sclerosis, Systemic

ArticleYear
Successful treatment of systemic-sclerosis-related digital ulcers with a selective endothelin type A receptor antagonist (sitaxentan).
    Dermatology (Basel, Switzerland), 2009, Volume: 219, Issue:2

    Topics: Adult; Amlodipine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedu

2009
[Anti-RNA polymerase III antibodies in scleroderma renal crisis].
    Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:22

    Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors;

2010
[Systemic sclerosis in a patient suffering from breast cancer].
    Magyar onkologia, 2012, Volume: 56, Issue:1

    Topics: Adult; Amlodipine; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Duct

2012